α-Internexin: A Novel Biomarker for Pancreatic Neuroendocrine Tumor Aggressiveness
Author(s) -
Bei Liu,
Laura H. Tang,
ZhaoJun Liu,
Mei Mei,
Run Yu,
Deepti Dhall,
Xinwei Qiao,
Taiping Zhang,
Yu-pei Zhao,
Tonghua Liu,
Yu Xiao,
Jie Chen,
Xiang Hong-ding,
Haiyan Wu,
Chongmei Lu,
Bin Lv,
Yaru Zhou,
Ye Zhang,
Dajun Deng,
YuanJia Chen
Publication year - 2014
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2013-2874
Subject(s) - biomarker , immunohistochemistry , neuroendocrine tumors , methylation , exon , biology , microbiology and biotechnology , cancer research , gene expression , western blot , gene , dna methylation , endocrinology , genetics , immunology
We aimed to test whether α-internexin could be a molecular biomarker of tumor aggressiveness and prognosis in pancreatic neuroendocrine tumors (PNETs).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom